Skip to content

Elaine Schattner

writer, health care advocate, physician

  • about
  • academic
  • journalist
  • patient advocate
  • portfolio
  • contact

oncology

7 Key Cancer Trends For 2018

7 Key Cancer Trends For 2018

A New PARP Drug For Breast Cancer? I’m Thrilled!

A New PARP Drug For Breast Cancer? I’m Thrilled!

Actually, Many New Cancer Drugs May Be Helpful And Worth Trying

Actually, Many New Cancer Drugs May Be Helpful And Worth Trying

A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It

A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It

Precision Oncology Drug Shows Power Of Cancer Genomics

Precision Oncology Drug Shows Power Of Cancer Genomics

Why The Movie About Henrietta Lacks Matters Today

Why The Movie About Henrietta Lacks Matters Today

Encouraging Results For Ribociclib In Advanced Breast Cancer

Encouraging Results For Ribociclib In Advanced Breast Cancer

Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game

Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer

The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology with permission, Maria Schwaederle, PharmD

The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology

MammaPrint, Agendia’s Breast Cancer Test, Is Having A U.S. Moment. Can It Reduce Overtreatment?

MammaPrint, Agendia’s Breast Cancer Test, Is Having A U.S. Moment. Can It Reduce Overtreatment?

Could New Lung Cancer Meds Keep Walter White From Breaking Bad? http://www.amc.com/shows/breaking-bad

Could New Lung Cancer Meds Keep Walter White From Breaking Bad?

Five Key Issues For The Future Of Cancer IT

Five Key Issues For The Future Of Cancer IT

Why Many Cancer Drugs Don’t Have To Cost So Much

Why Many Cancer Drugs Don’t Have To Cost So Much

Companion Diagnostics? For Cancer Care, We Need Better Ones

Companion Diagnostics? For Cancer Care, We Need Better Ones

Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients

Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients

Precision Medicine Will (Eventually) Lower Cancer Care Costs

Precision Medicine Will (Eventually) Lower Cancer Care Costs

In A First, Kidney Cancer Drug Extends Survival

In A First, Kidney Cancer Drug Extends Survival

Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value

Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value

Can Journalists Be Too Skeptical About Progress Against Cancer?

Can Journalists Be Too Skeptical About Progress Against Cancer?

On The Death Of Beau Biden, Brain Cancer, Progress And Hope

On The Death Of Beau Biden, Brain Cancer, Progress And Hope

Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors

Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors

Thinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In Cancer

Thinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In Cancer

Chatting With Anne Parker: A Patient’s View On How Cancer Care Has Changed Since The 1960s

Chatting With Anne Parker: A Patient’s View On How Cancer Care Has Changed Since The 1960s

Heart Health After Cancer: A Growing Concern

Heart Health After Cancer: A Growing Concern

On The Death Of David Carr, And Cancer Survivorship

On The Death Of David Carr, And Cancer Survivorship

Novel Drug Expands Treatment Options For Women With Metastatic Breast Cancer

Novel Drug Expands Treatment Options For Women With Metastatic Breast Cancer

Why The FDA Panel’s Nod To Sandoz’s Filgrastim (Zarzio) Is Good News For Patients

Why The FDA Panel’s Nod To Sandoz’s Filgrastim (Zarzio) Is Good News For Patients

Why Yes, We Should Treat Cancer

Why Yes, We Should Treat Cancer

What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer

What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer

For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy

For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy

At Palliative Care In Oncology Symposium, A Burst Of Energy

At Palliative Care In Oncology Symposium, A Burst Of Energy

Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors?

Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors?

The (Unmet) Potential Value of Cancer Genome Testing

The (Unmet) Potential Value of Cancer Genome Testing

Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices

Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Posts navigation

Previous
  • clips
  • breast cancer
  • breast cancer screening
  • precision oncology
  • survivorship
  • being a patient
  • being a doctor
  • health care policy
  • notes on TV, movies, plays, books, music…
Proudly powered by WordPress | Theme: Sketch by WordPress.com.
Elaine Schattner
Proudly powered by WordPress Theme: Sketch.